Sfoglia per Rivista HAEMATOLOGICA
Fenotipo clinico, valutazione immunologia e analisi molecolare in pazienti affetti da trombocitemia isolata X-recessiva (XLT)
2008-01-01 Notarangelo, L. D.; Giliani, Silvia Clara; Moratto, D; Mazza, C; Soresina, A; D'Ippolito, Carmelita; Tettoni, K; Soresian, R; Verdoni, L; Ricci, F; Meda, Spaccamela; Noris, P; Jankovic, M; LA DOGANA, S; COSSU F., DE MATTIA D; Notarangelo, L. D.; Porta, F.
FIP1L1-PDGFRA fusion gene as a therapeutic target of imatinib in hypereosinophilic syndrome: clinical and biological features.
2004-01-01 Martinelli, G; Ottaviani, E; Cilloni, D; Malagola, Michele; Rondoni, M; Bosi, C; Gottardi, E; Rosti, Ga; Ricci, P; Gaitani, S; Pane, F; Testoni, N; Mecucci, C; Soverini, S; Piccaluga, Pp; Amabile, M; Tiribelli, M; Poerio, A; Zuffa, E; Zaccaria, A; Grafone, T; De Vivo, A; Ascani, S; Pileri, Sa; Vivaldi, P; Giuseppe, V; Fattori, Pp; Bocchia, M; Serra, A; Maurillo, L; Fanin, R; Cross, N; Bertieri, N; Baccarani, M; Saglio, G; Merante, S; Cazzola, C; Alimena, G; Frassoni, F; Galieni, P; Ballerini, Pf; Danesin, C; Tecchio, C; Morandi, S; De Biase, E; Russo, Domenico; Gobbi, M; Gugliotta, L; Lauria, F; Mazza, P; Ferrara, F; Gherlinzoni, F; Leoni, P; Musto, P; Bernasconi, P; Majolino, I; Liberati, M.
FLAIE (Fludarabine, cytarabine, idarubicin and etoposide) induction chemotherapy for adult acute myeloid leukemia. Results of a pilot study
2009-01-01 Candoni, A; Tiribelli, M; Simeone, E; Volpetti, S; Florio, E; Malagola, Michele; Damiani, D; Russo, Domenico; Fanin, R.
Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia
1998-01-01 Russo, Domenico; Candoni, A.; Grattoni, R.; Bertone, A.; Zaja, F.
Fludarabine, Arabinosil cytosine, Idaubicine (FLAI): a combination of a non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia.
2003-01-01 Russo, Domenico; Damiani, D; Martinelli, G; Candoni, A; Pricolo, G; Pierri, I; Zuffa, E; Raspadori, D; Bocchia, M; Michelutti, A; De Vivo, A; Malagola, Michele; Testoni, N; Amabile, M; Mazza, P; Gobbi, M; Zaccaria, A; Lauria, F; Fanin, R; Visani, G; Baccarani, M.
Fludarabine, arabynosil cytosine and idarubicine (FLAI), a combination of non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia
2004-01-01 Malagola, Michele; Damiani, D; Russo, Domenico; Martinelli, G; Candoni, A; Michelutti, A; De Vivo, A; Testoni, N; Mazza, P; Gobbi, M; Zaccaria, A; Lauria, F; Fanin, R; Visani, G; Baccarani, M.
Fludarabine, AraC and Idarubicin versus Idarubicin, AraC and Etoposide for induction treatment of younger newly diagnosed AML patients: a multicenter phase III trial.
2006-01-01 Martinelli, G; Russo, Domenico; Malagola, Michele; de Vivo, A; Piccaluga, Pp; Paolini, S; Damiani, D; Candoni, A; Testoni, N; Ottaviani, E; Rondoni, M; Mazza, P; Zaccaria, A; Lauria, F; Avanzini, P; Baccarani, M.
Fludarabine, Cytarabine, Idarubicine and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed AML: results of a multicentric phase III italian sttudy.
2011-01-01 Papayannidis, C; Iacobucci, I; Candoni, A; Abbenante, Mc; Paolini, S; Malagola, Michele; Ottaviani, E; Lonetti, A; Curti, A; Parisi, S; Testoni, N; Lama, B; Maccarani, M; Martinelli, G.
Four Drugs combination (Fludarabine, Cytarabine, Idarubicin, Etoposide) as induction therapy for newly diagnosed acute myeloid leukemia patients younger than 65 yrs: response and follow up of 127 patients.
2011-01-01 Rondoni, M; Candoni, A; Aprile, L; Malagola, Michele; Paolini, S; De Santis, G; Defina, M; Piccaluga, Pp; Papayannidis, C; Usai, S; Crupi, R; Gozzetti, A; Iacobucci, I; Fanin, R; Russo, Domenico; Baccarani, M; Bocchia, M; Martinelli, G; Lauria, F.
Four-drugs induction intensified regimens (idarubicin, cytarabine and etoposide plus fludarabine or mylotarg – FLAIE and MyAIE) for acute myeloid leukemia. Results of a pilot study.
2007-01-01 Paolini, S; Piccaluga, Pp; Rondoni, M; Malagola, Michele; Papayannidis, C; Laterza, C; Verlicchi, L; De Rosa, F; Ottaviani, E; Iacobucci, I; Russo, Domenico; Candoni, A; Fanin, R; Visani, G; Baccarani, M; Martinelli, G.
FUNCTIONAL DEFICIT OF IL-10 IN NEUTROPHILS AND MONOCYTES AS A ARESULT OF ALTERED INFLAMMATORY RESPONSE IN PATIENTS WITH HYPER IGE SYNDROME
2010-01-01 Bertulli, C.; Giacomelli, M.; Bertolini, R.; Tamassia, N.; Tassone, L; Soresina, A.; Plebani, Alessandro; Bazzoni, F.; Badolato, Raffaele
Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases
2007-01-01 Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga, Pp; Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Priccolo, G; Gugliotta, L; Bonini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, Am; Fil, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico
Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases.
2007-01-01 Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga PP3 Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, A; Filì, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico
GENOMIC ANALISYS OF NOTCH MUTATIONS IN CASE OF ALAGILLE SYNDROME WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2013-01-01 Bernardi, S; Tononi, P; Marin Vergas, S; Bassi, G; Ambrosetti, A; Meneghini, V; Scaffidi, L; Mertinelli, G; Iacobucci, I; Delledonne, M; Krampera, M
Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency
2000-01-01 Lanfranchi, A; Verardi, R; Tettoni, K; Neva, A; Mazzolari, Evelina; Pennacchio, M; Pasic, S; Ugazio, Ag; Albertini, A; Porta, F.
Human immunodeficiency virus testing in acute leukemia patients transufsed between 1978 and 1985: a retrospective study in 91 cases.
1989-01-01 Visani, G.; Re, M. C.; Colombini, R.; Cenacchi, A. R.; Furlini, G.; Sermasi, G.; Tosi, P.; Rosti, G.; Russo, Domenico; Zuffa, E.; Cuppini, A.; Zucchelli, P.; Motta, M. R.; Sacchi, R.; Tura, S.
Hypereosinophilic sindrome treated with imatinib therapy: clinical and biological analysis.
2003-01-01 Martinelli, G; Ottavini, E; Testoni, N; Rosti, G; Poverini, S; Malagola, Michele; Piccaluga, Pp; Giannini, B; Luatti, S; Grafone, T; Amabile, M; Bianchini, M; Terragna, C; Poerio, A; Tonelli, M; Nicci, C; Baccarani, M.
Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning
2003-01-01 Cremonesi, L; Foglieni, B; Fermo, I; Cozzi, A; Paroni, R; Ruggeri, G; Belloli, S; Levi, S; Fargion, S; Ferrari, M; Arosio, Paolo
Imatinib in adult and elderly Ph+ ALL patients: preliminary results of the GIMEMA prospective study LAL0201.
2004-01-01 Vignetti, M; Fazi, P; Meloni, G; Chiarenza, A; Malagola, Michele; Fabbiano, F; Recchia, A; Kropp, Mg; Offidani, M; Palmieri, S; Cilloni, D; Torelli, G; Elia, L; Ribersani, M; Baccarani, M; Mandelli, F.
Imatinib mesylate as experimental therapy in systemic mastocytosis with D816V c-kit mutation but without FIP1L1-PDGFR-alpha fusion transcript.
2004-01-01 Rondoni, M; Malagola, Michele; Piccaluga, Pp; Gaitani, S; Soverini, S; Ottaviani, E; Rosti, G; Ricci, P; Testoni, N; Poerio, A; Grafone, T; De Vivo, A; Amabile, M; Bosi, C; Baccarani, M; Martinelli, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Fenotipo clinico, valutazione immunologia e analisi molecolare in pazienti affetti da trombocitemia isolata X-recessiva (XLT) | 1-gen-2008 | Notarangelo, L. D.; Giliani, Silvia Clara; Moratto, D; Mazza, C; Soresina, A; D'Ippolito, Carmelita; Tettoni, K; Soresian, R; Verdoni, L; Ricci, F; Meda, Spaccamela; Noris, P; Jankovic, M; LA DOGANA, S; COSSU F., DE MATTIA D; Notarangelo, L. D.; Porta, F. | |
| FIP1L1-PDGFRA fusion gene as a therapeutic target of imatinib in hypereosinophilic syndrome: clinical and biological features. | 1-gen-2004 | Martinelli, G; Ottaviani, E; Cilloni, D; Malagola, Michele; Rondoni, M; Bosi, C; Gottardi, E; Rosti, Ga; Ricci, P; Gaitani, S; Pane, F; Testoni, N; Mecucci, C; Soverini, S; Piccaluga, Pp; Amabile, M; Tiribelli, M; Poerio, A; Zuffa, E; Zaccaria, A; Grafone, T; De Vivo, A; Ascani, S; Pileri, Sa; Vivaldi, P; Giuseppe, V; Fattori, Pp; Bocchia, M; Serra, A; Maurillo, L; Fanin, R; Cross, N; Bertieri, N; Baccarani, M; Saglio, G; Merante, S; Cazzola, C; Alimena, G; Frassoni, F; Galieni, P; Ballerini, Pf; Danesin, C; Tecchio, C; Morandi, S; De Biase, E; Russo, Domenico; Gobbi, M; Gugliotta, L; Lauria, F; Mazza, P; Ferrara, F; Gherlinzoni, F; Leoni, P; Musto, P; Bernasconi, P; Majolino, I; Liberati, M. | |
| FLAIE (Fludarabine, cytarabine, idarubicin and etoposide) induction chemotherapy for adult acute myeloid leukemia. Results of a pilot study | 1-gen-2009 | Candoni, A; Tiribelli, M; Simeone, E; Volpetti, S; Florio, E; Malagola, Michele; Damiani, D; Russo, Domenico; Fanin, R. | |
| Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia | 1-gen-1998 | Russo, Domenico; Candoni, A.; Grattoni, R.; Bertone, A.; Zaja, F. | |
| Fludarabine, Arabinosil cytosine, Idaubicine (FLAI): a combination of a non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia. | 1-gen-2003 | Russo, Domenico; Damiani, D; Martinelli, G; Candoni, A; Pricolo, G; Pierri, I; Zuffa, E; Raspadori, D; Bocchia, M; Michelutti, A; De Vivo, A; Malagola, Michele; Testoni, N; Amabile, M; Mazza, P; Gobbi, M; Zaccaria, A; Lauria, F; Fanin, R; Visani, G; Baccarani, M. | |
| Fludarabine, arabynosil cytosine and idarubicine (FLAI), a combination of non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia | 1-gen-2004 | Malagola, Michele; Damiani, D; Russo, Domenico; Martinelli, G; Candoni, A; Michelutti, A; De Vivo, A; Testoni, N; Mazza, P; Gobbi, M; Zaccaria, A; Lauria, F; Fanin, R; Visani, G; Baccarani, M. | |
| Fludarabine, AraC and Idarubicin versus Idarubicin, AraC and Etoposide for induction treatment of younger newly diagnosed AML patients: a multicenter phase III trial. | 1-gen-2006 | Martinelli, G; Russo, Domenico; Malagola, Michele; de Vivo, A; Piccaluga, Pp; Paolini, S; Damiani, D; Candoni, A; Testoni, N; Ottaviani, E; Rondoni, M; Mazza, P; Zaccaria, A; Lauria, F; Avanzini, P; Baccarani, M. | |
| Fludarabine, Cytarabine, Idarubicine and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed AML: results of a multicentric phase III italian sttudy. | 1-gen-2011 | Papayannidis, C; Iacobucci, I; Candoni, A; Abbenante, Mc; Paolini, S; Malagola, Michele; Ottaviani, E; Lonetti, A; Curti, A; Parisi, S; Testoni, N; Lama, B; Maccarani, M; Martinelli, G. | |
| Four Drugs combination (Fludarabine, Cytarabine, Idarubicin, Etoposide) as induction therapy for newly diagnosed acute myeloid leukemia patients younger than 65 yrs: response and follow up of 127 patients. | 1-gen-2011 | Rondoni, M; Candoni, A; Aprile, L; Malagola, Michele; Paolini, S; De Santis, G; Defina, M; Piccaluga, Pp; Papayannidis, C; Usai, S; Crupi, R; Gozzetti, A; Iacobucci, I; Fanin, R; Russo, Domenico; Baccarani, M; Bocchia, M; Martinelli, G; Lauria, F. | |
| Four-drugs induction intensified regimens (idarubicin, cytarabine and etoposide plus fludarabine or mylotarg – FLAIE and MyAIE) for acute myeloid leukemia. Results of a pilot study. | 1-gen-2007 | Paolini, S; Piccaluga, Pp; Rondoni, M; Malagola, Michele; Papayannidis, C; Laterza, C; Verlicchi, L; De Rosa, F; Ottaviani, E; Iacobucci, I; Russo, Domenico; Candoni, A; Fanin, R; Visani, G; Baccarani, M; Martinelli, G. | |
| FUNCTIONAL DEFICIT OF IL-10 IN NEUTROPHILS AND MONOCYTES AS A ARESULT OF ALTERED INFLAMMATORY RESPONSE IN PATIENTS WITH HYPER IGE SYNDROME | 1-gen-2010 | Bertulli, C.; Giacomelli, M.; Bertolini, R.; Tamassia, N.; Tassone, L; Soresina, A.; Plebani, Alessandro; Bazzoni, F.; Badolato, Raffaele | |
| Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases | 1-gen-2007 | Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga, Pp; Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Priccolo, G; Gugliotta, L; Bonini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, Am; Fil, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico | |
| Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases. | 1-gen-2007 | Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga PP3 Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, A; Filì, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico | |
| GENOMIC ANALISYS OF NOTCH MUTATIONS IN CASE OF ALAGILLE SYNDROME WITH ACUTE LYMPHOBLASTIC LEUKEMIA | 1-gen-2013 | Bernardi, S; Tononi, P; Marin Vergas, S; Bassi, G; Ambrosetti, A; Meneghini, V; Scaffidi, L; Mertinelli, G; Iacobucci, I; Delledonne, M; Krampera, M | |
| Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency | 1-gen-2000 | Lanfranchi, A; Verardi, R; Tettoni, K; Neva, A; Mazzolari, Evelina; Pennacchio, M; Pasic, S; Ugazio, Ag; Albertini, A; Porta, F. | |
| Human immunodeficiency virus testing in acute leukemia patients transufsed between 1978 and 1985: a retrospective study in 91 cases. | 1-gen-1989 | Visani, G.; Re, M. C.; Colombini, R.; Cenacchi, A. R.; Furlini, G.; Sermasi, G.; Tosi, P.; Rosti, G.; Russo, Domenico; Zuffa, E.; Cuppini, A.; Zucchelli, P.; Motta, M. R.; Sacchi, R.; Tura, S. | |
| Hypereosinophilic sindrome treated with imatinib therapy: clinical and biological analysis. | 1-gen-2003 | Martinelli, G; Ottavini, E; Testoni, N; Rosti, G; Poverini, S; Malagola, Michele; Piccaluga, Pp; Giannini, B; Luatti, S; Grafone, T; Amabile, M; Bianchini, M; Terragna, C; Poerio, A; Tonelli, M; Nicci, C; Baccarani, M. | |
| Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning | 1-gen-2003 | Cremonesi, L; Foglieni, B; Fermo, I; Cozzi, A; Paroni, R; Ruggeri, G; Belloli, S; Levi, S; Fargion, S; Ferrari, M; Arosio, Paolo | |
| Imatinib in adult and elderly Ph+ ALL patients: preliminary results of the GIMEMA prospective study LAL0201. | 1-gen-2004 | Vignetti, M; Fazi, P; Meloni, G; Chiarenza, A; Malagola, Michele; Fabbiano, F; Recchia, A; Kropp, Mg; Offidani, M; Palmieri, S; Cilloni, D; Torelli, G; Elia, L; Ribersani, M; Baccarani, M; Mandelli, F. | |
| Imatinib mesylate as experimental therapy in systemic mastocytosis with D816V c-kit mutation but without FIP1L1-PDGFR-alpha fusion transcript. | 1-gen-2004 | Rondoni, M; Malagola, Michele; Piccaluga, Pp; Gaitani, S; Soverini, S; Ottaviani, E; Rosti, G; Ricci, P; Testoni, N; Poerio, A; Grafone, T; De Vivo, A; Amabile, M; Bosi, C; Baccarani, M; Martinelli, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile